One recent study of reports from the FDAs Adverse Event Reporting System database found that less than 5 percent of complaints about GLP-1s were related to psychiatric symptoms, but GLP-1s were more likely than other medications to be linked to nervousness, stress, eating disorders, fear of injection, insomnia, binge eating, fear of eating, and self-induced vomiting
This can be attributed to Novo Nordisks SELECT trial, which demonstrated the cardiovascular benefits of semaglutide
If you have epilepsy or other seizure disorders, discuss DSIP thoroughly with your neurologist
I had a lot of issues with my knees, especially after I had my kid, she said
The clinical evidence base for semaglutide in weight management is substantial
He will assess your individual health needs and develop a plan that ensures both your weight loss program and TRT treatment are managed for optimal health and wellness